Demant A/S ADR (WILYY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Demant A/S ADR (WILYY) is up 26.1% since the beginning of the year. At $21 per share, WILYY is currently trading at its 52-week high. Investors who bought $1,000 worth of WILYY shares 5 years ago would now be looking at an investment worth $691.

Demant A/S ADR (WILYY) has returned 26.05% so far this year and 2.33% over the past 12 months. Over the last ten years, WILYY has returned 7.69% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.

Based on dividend-adjusted daily data since Jun 24, 2011, WILYY's average daily return is +0.03%, while the average monthly return is +0.59%. At this rate, an investment would double in approximately 9.8 years.

Historically, 43% of months were positive and 57% were negative. The best month was Nov 2019 with a return of +25.8%, while the worst month was Jun 2016 at -54.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, WILYY closed higher 13% of trading days. The best single day was Feb 23, 2017 with a return of +20.1%, while the worst single day was Jun 24, 2016 at -52.1%.

Demant A/S ADR has an annualized alpha of 5.17%, beta of 0.23, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since June 24, 2011.

• This stock participated in 62.07% of S&P 500 Index downside but only 31.52% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.23 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

WILYY ranks 46 for risk / return — above 46% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Demant A/S ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Demant A/S ADR was 62.72%, occurring on Nov 3, 2022. The portfolio has not yet recovered.

The current Demant A/S ADR drawdown is 31.18%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Demant A/S ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Demant A/S ADR is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.